Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
5,856
datasets available to search
ShareScore release 0.9.0
Dataset results
5,856 results for “B cells”
Alisertib With and Without Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01812005. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab
ClinicalTrials.gov study NCT04998851. IPD Sharing: YES. Countries: 3. Publications: 0.
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy
ClinicalTrials.gov study NCT04359784. IPD Sharing: NO. Countries: 1. Publications: 0.
Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00230282. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Chinese Participants With B-Cell Malignancies With BGB-16673, a Bruton Tyrosine Kinase-Targeted Protein-Degrader
ClinicalTrials.gov study NCT05294731. IPD Sharing: YES. Countries: 1. Publications: 0.
89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT04566978. IPD Sharing: YES. Countries: 1. Publications: 0.
Safety/Efficacy of MEDI-551 in Combination With Immunomodulating Therapies in Subjects With Aggressive B-cell Lymphomas
ClinicalTrials.gov study NCT02271945. IPD Sharing: Not stated. Countries: 1. Publications: 0.
VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas
ClinicalTrials.gov study NCT01289210. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib Post Stem Cell Transplantation (SCT) in Double-Hit B-Cell Lymphoma
ClinicalTrials.gov study NCT02272686. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Pembrolizumab in Relapsed and Refractory Gray-Zone Lymphoma (GZL), Primary Central Nervous System Lymphoma (PCNSL), and Other Extranodal Diffuse Large B-cell Lymphomas
ClinicalTrials.gov study NCT03255018. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of Radiation Therapy Before CAR T Cell Therapy for People With B Cell Lymphoma
ClinicalTrials.gov study NCT05574114. IPD Sharing: YES. Countries: 1. Publications: 0.
PK,PD,Safety and Tolerability of Multiple Dose Regimens of MT-3724 With Gemcitabine and Oxaliplatin for the Treatment of Patients With Relapsed/Refractory Diffuse Large B Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03488251. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies
ClinicalTrials.gov study NCT04277637. IPD Sharing: YES. Countries: 7. Publications: 0.
CD19.CAR Allogeneic NKT for Patients With Relapsed or Refractory B-Cell Malignancies (ANCHOR)
ClinicalTrials.gov study NCT03774654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Rituximab-HCVAD Alternating With Rituximab-Methotrexate-Cytarabine Versus Standard Rituximab-CHOP Every 21 Days for Patients With Newly Diagnosed High Risk Aggressive B-Cell Non-Hodgkin's Lym
ClinicalTrials.gov study NCT00290498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Loncastuximab Tesirine and Rituximab (Lonca-R) in Previously Untreated Unfit/Frail Participants With Diffuse Large B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT05144009. IPD Sharing: NO. Countries: 4. Publications: 0.
Pegfilgrastim and Combination Chemotherapy With or Without Rituximab in Treating Older Patients With Aggressive B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00726700. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Rituximab, Pentostatin, Cyclophosphamide, and Lenalidomide in Treating Patients With Previously Untreated B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT00602836. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Clinical Study of ONCT-808 in Subjects With Relapsed or Refractory B-Cell Malignancies
ClinicalTrials.gov study NCT05588440. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase 2 Study of Plamotamab Combined With Tafasitamab Plus Lenalidomide Versus Tafasitamab Plus Lenalidomide in Relapsed or Refractory (R/R) Diffuse Large-cell B-cell Lymphoma (DLBCL)
ClinicalTrials.gov study NCT05328102. IPD Sharing: Not stated. Countries: 3. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.